A major advance in cancer investigation is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently lost in various kinds of tumors, leading https://ilovebookmarking.com/story21949699/mini-antibodies-reactivate-the-p53-protein-a-promising-hope-for-malignant-treatment